Home > European Cancer Organisation Highlights
    • FILTER YOUR SEARCH
    Speciality:
    More Specialities

    • European Cancer Organisation Highlights

    COVID-19
    Mark Lawler, European Cancer Summit 2020 – Impact of COVID-19 on Cancer

    The COVID-19 pandemic has had a huge impact on us all, but particularly patients with cancer. Prof. Mark Lawler tells touchONCOLOGY about the data he presented at this year’s European Cancer Summit, the challenges patients with cancer face as a result of the pandemic, and steps taken to help mitigate this effect. Questions You presented […]

    Diagnostics and Screening
    Isabel T Rubio, European Cancer Summit 2020 – Primary Prevention Network

    Dr Isabel T Rubio, Co-Chair of the European Cancer Organisation Primary Prevention Network, joins us to discuss outcomes of this year’s European Cancer Summit and the resolutions to improve screening and early detection of cancer across Europe. Questions How do you expect the cancer burden in Europe to change in the coming years, and is […]

    Supportive Cancer Care
    Nicolò Matteo Luca Battisti, European Cancer Summit 2020 – Inequalities in Cancer Care

    Discrimination in cancer care is a major ongoing issue across Europe and has been exacerbated during the COVID-19 pandemic. Nicolò Matteo Luca Battisti discusses how the resolution from this year’s European Cancer Summit will help overcome these disparities. Questions Could you give us an overview of the issue of discrimination in cancer care? What are […]

    Policy
    Stefan Gijssels, Eureopean Cancer Summit 2020 – The Beating Cancer Plan
    Stefan Gijssels

    touchONCOLOGY means Stefan Gijssels at the European Cancer Summit 2020 to discuss the Beating Cancer Plan and key highlights and outcomes from this year’s meeting. Questions How do you expect the cancer burden in Europe to change in the coming years? What are the aims and main components of the Beating Cancer Plan? What initiatives […]

    Policy
    Françoise Meunier, European Cancer Summit 2020 – Financial Toxicity and the ‘Right to be Forgotten’
    Françoise Meunier,

    Dr Françoise Meunier, Vice President of the Federation of European Academies of Medicine, joins touchONCOLOGY to discuss financial toxicity in patients with cancer and progress made with the “Right to be Forgotten” resolution made at the European Cancer Summit in 2018. Questions What does the term ‘financial toxicity’ mean, and what does it mean for […]

    Policy
    Daniel Kelly, European Cancer Summit 2020 – HPV Action Network
    Daniel Kelly

    touchONCOLOGY joins Prof. Daniel Kelly to discuss the aims and scope of the European Cancer Organisation HPV Action Network. Questions What are the aims of the HPV Action Network? How can HPV-associated cancers be reduced and why is this resolution important? Could you tell us about the European Cancer Organisation’s recent action plan and report, […]

    Policy
    Andreas Charalambous, European Cancer Summit 2020 – Preparing a Resilient Oncology Workforce for the Present and Future
    Andreas Charalambous

    touchONCOLOGY joins Prof. Andreas Charalambous at the European Cancer Summit 2020 to discuss the work of the Workforce Network and the resolution that arose from the summit’s audience. Questions What issues does the Workforce Network aim to address? What can be done in Europe to strengthen education and training? What was the European Cancer Summit’s […]

    Policy
    Matti Aapro – ECCO 2019 European Cancer Summit

    It was an honour for touchONCOLOGY to catch up with one of our editorial board members and ECCO President-Elect Matti Aapro at the ECCO 2019 European Cancer Summit in Brussels to discuss molecular tumour diagnostics in cancer care. Questions 1. In what key areas should molecular tumour diagnostics improve cancer detection and subsequent care? (0:10) […]

    Policy
    Mark Lawler – ECCO 2019 European Cancer Summit

    touchONCOLOGY met Professor Mark Lawler (Chair, Translational Cancer Genomics Centre for Cancer Research and Cell Biology (CCRCB), Queen’s University Belfast) at the ECCO 2019 European Cancer Summit in Brussels to discuss the EU Cancer Mission and the work of the Lancet Oncology Cancer Groundshot. Questions 1. What do the big-data, patient-centered (high-cost) research initiatives such […]

    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72